Facilitation of mechanical ventilation of the lungs using an infusion of vecuronium in 11 it~Tnts and children and four neonates in an intensive
Accepted for publication 6th November, 1990. heures. La Children admitted to an intensive care unit may require mechanical ventilation of the lungs. As in adults the use of muscle relaxants in this context is decreasing. However, it has been shown that the use of pancuronium to facilitate mechanical ventilation speeds the recovery of infants suffering from hyaline membrane disease.~ In addition, neuromuscular blocking agents may be required to facilitate intermittent positive-pressure ventilation when lung compliance is low or when the patient is being stabilised on ventilation.
Traditionally, agents such as pancuronium and dtubocurarine have been used to facilitate mechanical ventilation. However, Fisher et al. 2 have shown that neonates and infants are more sensitive than adults to d-tubocurarine. Similar sensitivity to pancuronium has been shown by Bennett et al. 3 Furthermore, a greater individual variation in the dose requirements of dtubocurarine in the paediatric age group has been demonstrated by Goudsouzian et al. 4 Consequently, using a long-acting muscle relaxant to facilitate mechanical ventilation in these circumstances may have unpredictable effects leading to overdosage and delayed recovery in some patients.
Vecuronium is a relatively short-acting neuromuscular blocking agent which is non-cumulative and, in addition, does not have the cardiovascular side-effects of the older muscle relaxants. 5 It would thus appear to be a suitable agent for use in the intensive care unit. However, because of its short duration of action, administration by an intermittent bolus technique could be impractical. The 
Methods
The study was reviewed and approved by the Hospital Medical Ethics Committee. A total of 15 patients requiring the administration of muscle relaxants to facilitate intermittent positive-pressure ventilation were admitted to the study; I 1 infants and children (mean age • SD: 35.2 -+ 38.7 mth), and four neonates (mean age +-SD: 5.3 -+-7.9 d). Neuromuscular block was established by administering an initial bolus dose of vecuronium of 0. I rag. kg -t. At the same time an infusion of vecuronium was commenced at a rate of O. I rag' kg-~ 9 hr-I. The vecuronium was delivered from a syringe pump dissolved in O. 18% saline in 4% dextrose in a concentration of 0.2 mg.ml -~. In fluid restricted patients the vecuronium concentration was doubled to 0.4 nag. ml -~. The degree of neuromuscular blockade was monitored using train-of-four (TOF) nerve stimulation of the ulnar nerve at the wrist or elbow using a Myotest peripheral nerve stimulator (Biometer Ltd). The aim was to maintain a constant block of the adductor pollicis of approximately 90% (one response to TOF stimulation). A note was made of the number of responses felt in the thumb in response to a TOF stimulation every 30 min. The infusion rate of the vecuronium was maintained constant unless the block remained at 100% (i.e., no response to TOF stimulation) or the block was less than 80% (i.e., three or more responses were present) for more than one hour. In these circumstances the infusion was reduced or increased by 10% of the original rate until one response was present. Recovery times were measured from the time of cessation of the vecuronium infusion to loss of apparent fade in response to a tetanic stimulation. This was done every three to four minutes.
Routine monitoring of the patients was in accordance with the practice of the unit and included ECG, direct arterial pressure and temperature measurement. Arterial blood gas and electrolyte measurements were carried out twice a day or more often if required and adjustments were made to ventilation and acid-base balance as necessary.
Sedation was provided by infusions of morphine (20-40 I~g'kg-' "hr -t) except in three neonates who received infusions of fentanyl ( 10-20 ixg 9 kg -t 9 hr-I).
Mean values and standard deviations were calculated for the durations of infusion, the dosage required and the time to recovery in the two subgroups of patients. The data were examined for correlation between the duration of infusion and the recovery time. Table I lists the details of the I I infants and children in the study. Patient #1 was treated with chloramphenicol and all the other children received a penicillin, aminoglycoside or a cephalosporin antibiotic. Except for patients #9 and # 10 who required a second bolus, a complete neuromuscular block was achieved following the initial bolus of 0. I mg. kg-i vecuronium. Table 11 lists the details of the vecuronium infusions in these infants and children. The duration of infusions varied from 13 to 179 hr. The dose of vecuronium varied from 0.1 mg.kg -~.hr -I to 0.27 mg.kg -I.hr -I with a mean of 0.14 mg. kg-I. hr-~ (---0.05). The total amount of vecuronium administered varied between 18.5 and 260 mg. Also listed is the number of alterations to the infusion rate required to keep the neuromuscular block constant.
Results
The time to recovery varied from 27 to 80 min with a mean of 51.7 min (_+.17.6). There was a positive correlation between the duration of the infusion and the time to recovery from the neuromuscular block in this group (r = 0.76; P < 0.01). Table I shows that 9 of the I I infants and children were discharged from the intensive care unit. The other two children died from the effects of pneumonia and head injury. All patients maintained a normal blood biochemistry throughout the study.
All four patients in the neonatal group (Table 111 ) achieved complete neuromuscular blockade with the loading dose of 0. I mg. kg-~ vecuronium. The duration of infusions (Table IV) 31 to 62 min with a mean of 47 min (--+ 16.5). There was no significant correlation between duration of the vecuronium infusion and time to recovery in this sub-group. All four neonates were discharged from the intensive care unit. All patients maintained normal blood biochemistry throughout the study. No patient exhibited any bradycardia or arrhythmias due to vecuronium administration.
Discussion
Neuromuscular blocking agents are used less frequently now in the intensive care unit to facilitate intermittent positive-pressure ventilation of patients. Emphasis is placed more upon adequate sedation. However, this does not always provide optimal ventilation and recourse has to be made to administration of a muscle relaxant in conjunction with the sedatives.
The present study demonstrates that it is feasible and satisfactory to administer vecuronium by an infusion technique to children in the intensive care unit. Furthermore, the study has shown that the degree of muscle CANADIAN JOURNAL OF ANAESTHESIA relaxation can be monitored using a nerve stimulator without need for transducers and recording equipment to ensure adequate neuromuscular blockade. The recovery after stopping the infusions appears to be relatively rapid. Even patient #8 (Table I1) , whose infusion lasted 179 hr, took only 80 rain to recover adequately from the block. In the infants and children the infusion rate varied from 0.07 mg. kg-i. hr-i to 0.27 rag. kg-~ 9 hr -t . The latter figure was obtained in a two-month-old, 4 kg, infant with congenital heart disease and oesophageal atresia. The mean infusion rate was 0.14 rag" kg -t . For these children the number of adjustments to the infusion rate varied from 2 to 45. The adjustments were required throughout the entire infusion period and not only in the early stages. There was a marked inter-patient variability in the number of adjustments required to the infusion. For example, patient #2 required only three changes to the infusion rate in 119.5 hr while patient #9 required 15 in 15.5 hr. This confirms the individual variability reported with vecuronium by various workers. 8 Animal work suggests that a metabolite of metronidazole may inhibit the metabolism of vecuronium. 9 However, patient #6 was receiving metronidazole yet the recovery (45 min) in this patient did not show any prolongation from the group mean (51.7 rain). This is in agreement with the findings of d'Hollander et al. ~~ Penicillin has been shown to have little effect on neuromuscular function while aminoglycosides prolong the effect of nondepolarizing muscle relaxants, t~ '12 In the present study neither penicillin nor the aminoglycosides appeared to prolong the activity of the vecuronium. Although phenytoin administration has been reported to induce resistance to vecuronium, ~3 this was not observed in the two patients receiving phenytoin in the present study, perhaps because these patients had received phenytoin for only a short time.
An important determinant of the duration of effects of drugs used by continuous infusion in the intensive therapy units is the status of renal function. It has been reported that the effect of vecuronium when used over long periods may be unduly prolonged in the presence of severe renal dysfunction. 14,~5 This is based on the decreased clearance of vecuronium and the cumulation of its active metabolite 3-desacetylvecuronium in patients with renal failure. ~-~'6 Delayed recovery was not a problem after the prolonged use of vecuronium in patients with good renal function in adults 7 and was not observed in the present study where the renal function was good. Nevertheless one must be conscious of this possibility. In 1955 Stead ~7 showed that the neonate was more sensitive than the adult to the effects of d-tubocurarine. More recent work has demonstrated that neonates are also more sensitive to the neuromuscular blocking effects of vecuronium. ~8 Neonates in the present study required a lower infusion rate, an average of 0.11 mg'kg -~'hrcompared with 0.14 mg.kg-l.hr -~ in the infants and children although this difference was not significant (P < 0.4). There was once again a marked variability in the dose requirements (Table IV) ; however, the results are based on only a very small group of patients. The dosage of vecuronium used in the present study in the neonates was higher than that reported by Meretoja.~9 However, vecuronium infusions in that study were being used over a relatively short time in ASA I or 11 patients undergoing elective surgery whereas patients in the present study required pulmunary ventilation for a much longer time due to the presence of infection and high metabolic rates. The lower requirements of vecuronium in children during prolonged infusions reported by Eldadah and Newth were probably because they maintained a more superficial block. 2~
Despite a positive correlation between the duration of the infusion and the recovery time in these infants and children, clinical recovery from the neuromuscular block was not unduly prolonged, the longest time being 80 rain in patient -#8 after an infusion of 179 hr. it does, however, emphasise the importance of monitoring the effects of the vecuronium being infused and tailoring the dose to each patient's requirements.
In conclusion, this study demonstrates the feasibility of administering vecuronium by infusion to children requiring neuromuscular blockade to facilitate intermittent positive pressure ventilation in the intensive care unit. Control of the infusion to maintain constant neuromuscular blockade was readily achieved using a peripheral nerve stimulator.
